REBIRTH, OE 8882, project: Transgenic expression of cytidine deaminase (CDD) and multidrug resistance gene 1 (MDR1) to optimise treatment strategies for acute leukemias and the myelodysplastic syndrome (MDS) [...] Dr. Anuhar Chaturvedi, Molecular Therapy, OE 6864, project: Transcriptional control of MN1 target genes Final exam June 2016. Eileen Hübschen (nee Frenzel) GERMANY supervisor: Prof. Dr. Janciauskiene,
Institute for Toxicology and Experimental Medicine, the Universities of Dresden and Aarhus (Denmark), Gene Center in München, the Institute of Protein Research (Russian Academy of Science), the synchrotron
Why can certain viruses and bacteria become particularly dangerous for some people? What role do genes and the immune system play in this? How can we predict the course of the disease, develop individual
one of the cancer disposition syndromes and is caused by a hereditary genetic alteration in the TP53 gene. Professor Kratz has been working on Li-Fraumeni syndrome for many years, and he is a globally networked
are fully financed for 3-4 years. Courses available outside the curriculum include: Animal Handling Gene Technology Omics and Bioinformatics Good Scientific Practise Master Class Lectures, Symposia LISA
Ferreira de Figueiredo (Transfusion Medicine) Project: Correction of monogenetic kidney diseases using a gene therapeutic approach Aavani Biju Sindhu INDIA; Sindhu.Aavani @ mh-hannover.de Supervisor: Prof. Dr [...] Felix @ mh-hannover.de Supervisor: Prof. Dr. Axel Schambach (Experimental Hematology) Project: Novel gene therapy strategies for inherited inner ear defects Lena Willmer GERMANY; lena.willmer @ item.fraunhofer
Robert @ mh-hannover.de Supervisor: Prof. Dr. Axel Schambach (Experimental Hematology) Project: Novel gene and immunotherapeutic approaches for the treatment of cervical cancer Pegah Rahmati IRAN Rahmati.Pegah [...] Pegah @ mh-hannover.de Supervisor: Prof. Dr. Britte Eiz-Vesper (Transfusion Medicine) Project: Gene-regulated EBV-specific T cells for personalized adoptive immunotherapy Final exam November 2024 Sonia
Institute of Experimental Hematology Project: Stem and progenitor cells for disease modeling and gene therapy of hearing loss Final exam November 2024 Christian Melcher GERMANY Melcher.Christian @ mh-hannover [...] Axel Schambach, Insitute of Experimental Haematology, Project: Development and validation of novel gene therapeutic approaches for correction of and protection from hearing loss Final exam June 2024 Dimyana
lity, injury response and repair of epithelial cells within the kidney and allograft. We focus on gene regulatory mechanisms that control aspects of epithelial differentiation, regeneration, and homeostasis [...] Rajewsky N#, Schmidt-Ott KM # : Kidney Single-cell Transcriptomes Predict Spatial Corticomedullary Gene Expression and Tissue Osmolality Gradients. Journal of the American Society of Nephrology, 32:291-306 [...] C, Popova E, Bader M, Dechend R, Staff AC, Yurtdas ZY, Kilic E, Schmidt-Ott KM: A Grhl2-dependent gene network controls trophoblast branching morphogenesis. Development, 142:1125-1136, 2015. Paragas N*
Hepatology and Endocrinology has found a way to treat the hereditary disease with the help of targeted gene correction. "The work seemed to us to be groundbreaking, highly innovative and extremely relevant